305 results about "Low blood pressures" patented technology

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula. Embodiments include catheter apparatus including an ablation element for creating and / or modifying the fistula. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least one predetermined wavelength of light is passed onto or through body tissues such as a finger, earlobe, or scalp, etc. and attenuation of light at that wavelength is detected. Likewise, the change in blood flow is determined by various techniques including optical, pressure, piezo and strain gage methods. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If an additional wavelength of light is used which attenuates light substantially differently by oxyhemoglobin and reduced hemoglobin, then the blood oxygen saturation value, independent of hematocrit may be determined. Further, if an additional wavelength of light is used which greatly attenuates light due to bilirubin (440 nm) or glucose (1060 nm), then the bilirubin or glucose value may also be determined. Also how to determine the hematocrit with a two step DC analysis technique is provided. Then a pulse wave is not required, so this method may be utilized in states of low blood pressure or low blood flow.

The invention relates to estimation of a patient's propensity to suffer from symptomatic hypotension during extracorporeal blood treatment. An electromagnetic test signal, which is applied over a thoracic region of the patient via at least one transmitter electrode. A result signal produced in response to the test signal is received via at least one receiver electrode on the patient. A test parameter is derived based on the result signal. The test parameter expresses a fluid status of the thoracic region of the patient, and it is determined whether the test parameter fulfills an alarm criterion. If the test parameter fulfills an alarm criteria, an alarm signal is generated. This signal indicates that the patient is hypotension prone, and that appropriate measures should be taken.

A method of cufflessly and non-invasively measuring blood pressure in a wrist region of a patient in association with a communication device that relays the information being measured includes: detecting a magnitude difference between a plurality of pulse wave signals detected from a wrist of a user; detecting feature points from an electrocardiogram (ECG) and pulse wave signals detected from the user; extracting variables needed to calculate the highest blood pressure and the lowest blood pressure using the detected feature points; and calculating the highest blood pressure and the lowest blood pressure of the user by deducing a scatter diagram using the extracted variables.

A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.

A highly refined cellulose material is a composition of matter is used as an ingredient in the preparation of a neutraceutical in liquid, solid, or tablet form. These compositions may provide an expectation of a health benefit selected from the group consisting of Antioxidation; Cancer prevention; Arterial health improvement; Cholesterol lowering; Reduced blood pressure; Skin and wrinkle treatment; and Prolonging and / or delaying release of a nutrient into a bloodstream.

The invention relates to a piezoelectric sensor for the improved measurement of mechanical variables such as force, pressure or measurement variables which are derived there from, particularly a PVDF film sensor having an improved sensitivity and temperature stability of the measurement signal for pressure measurements that vary in time and / or space, and for the one- and two-dimensional determination of the position and propagation velocity of pressure fluctuations and pressure waves with a single measurement sensor at a measurement location. A preferred field of application of the invention is the non-invasive, low strain and continuous measurement of the pulse rate and the systolic and diastolic blood pressure of humans and animals by determining the velocity and the signal form of the pulse waves. The object of the invention is to allow the measurements of the blood pressure and the pulse rate, for example even in the case of emergency patients having only a very low blood pressure and patients having circulatory disorders in the extremities, for example patients which have developed diabetes or the “smoker's leg”, by using only one sensor at a measurement location due to the improved measurement sensitivity of the piezoelectric sensor, with the result that the continuous application of a pressurized jacket for continuously measuring and monitoring the blood pressure is not necessary. The present invention solves this problem in that a plurality of parallel strips of a piezoelectric material (1) are associated as a measurement membrane in the pressure sensor according to the invention with a sensor base body (4) in such a manner that the parallel strips are tension preloaded in a one-dimensional and elastic manner in the direction of the piezo dipole orientation and that an empty cavity (5) is provided between the tension preloaded piezoelectric sensor material (1) in the measurement portion and the sensor base body (4), formed by a recess / cutout.

The invention relates to a method for processing a beverage by taking natural plants as raw materials, in particular to a cold brewed herbal tea and a preparation method thereof. The cold brewed herbal tea is processed by using the raw materials such as medical stone, honeysuckle, mulberry leaves, momordica grosvenori, dandelion, tea powder, pollen and the like. The cold brewed herbal tea has the good effects of clearing heat and detoxicating, protecting health, beautifying, treating anemopyretic cold, improving eyesight and removing heat from the liver, relieving cough, relieving summer heat and quenching thirst, relaxing bowel, regulating blood sugar level, reducing blood fat, lowering blood pressure, refreshing, digesting, promoting urination and the like.

A triple drug, pharmaceutical kit, composition, and method of treatment containing a combination of effective amounts of at least one anxiolytic agent, at least one centrally acting alpha antiadrenergic agent, and at least one central nervous system stimulant for the reduction or prevention of alcohol and narcotic withdrawal side effects of dizziness, drowsiness, depression, lethargy, orthostatic hypotension, weakness in the extremities, and difficulty in being mobile, caused by therapeutic agents utilized for the treatment of alcohol or narcotic withdrawal symptoms in patients overcoming alcohol or narcotic addiction.

The invention relates to a fruit and vegetable yogurt drink and a preparation method thereof. The method comprises the following steps: selecting excellent apples, cucumbers, carrots, radishes, aloes, mango, pineapple, yangtao, sweet potatoes, tomatoes and milk; cleaning and processing the raw materials; preparing fruit and vegetable juice, and homogenizing and degassing the fruit and vegetable juice; mixing the fruit and vegetable juice with the milk; fermenting, homogenizing and sterilizing; cooling and bulking; checking and warehousing. The fruit and vegetable yogurt drink disclosed by the invention achieves micro-molecularization after being juiced, can be absorbed by a human body more easily, has the characteristics of being pleasant in sweetness and sourness, comprehensive and abundant in nutrition, and appetizing, contains a plurality of natural mineral substances such as dietary fibers, protein, vitamin B2, vitamin C, vitamin E, superoxide dismutase (SOD), carotene, nicotinic acid, calcium, phosphorus, ferrum, potassium, copper and selenium, is an excellent yogurt drink, and also has the effects of stimulating a digestive system and an inner circulation system, reducing blood pressure, preventing cancers, clearing away heat and toxic materials, inducing saliva and slaking thirst, tonifying spleen and reinforcing the stomach, eliminating toxin and beautifying skin, and preventing blurring of image.

A method and system for the extracorporeal treatment of blood to remove fluid from the fluid overloaded patient is disclosed that non-invasively measures osmotic pressure across a filter membrane of a blood filter. The filter is permeable to water and electrolytes, but not to blood protein. The osmotic pressure indicates the protein concentration in the blood. Osmotic pressure is used to detect when hypotension is about to occur in a patient, as a result of excessive blood volume reduction during treatment of the blood. Using the osmotic pressure measurement as a feedback signal, the rate of fluid extraction is automatically controlled to achieve the desired clinical outcome and avoid precipitating a hypotensive crisis in the patient.

A once-a-day oral milnacipran modified release formulation has been developed. The formulation comprises an extended release dosage unit (optionally containing the immediate release portion) coated with delayed release coating. The milnacipran composition, when administered orally, first passes through the stomach releasing from zero to less than 10% of the total milnacipran dose and then enters the intestines where drug is released slowly over an extended period of time. The release profile is characterized by a 0.05-4 hours lag time period during which less than 10% of the total milnacipran dose is released followed by a slow or extended release of the remaining drug over a defined period of time. The composition provides in vivo drug plasma levels characterized by Tmax at 4-10 hours and an approximately linear drop-off thereafter and Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition provides a therapeutic effect over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.

An apparatus and method of temporarily replacing the function of the left ventricle in a patient whose heart is severely injured and is unable to maintain a systemic arterial pressure adequate to support the inside walls of patient's aorta, the method comprising a removable pressurizable support means having an external profile which is expandable to fit firmly against the inside wall of the aorta of a patient, wherein the external profile of the pressurizable support means presents a central opening that allows blood to flow through the aorta. The pressurizable support means can both support and expand the aorta under low blood pressure to assist the drawing of blood from the left ventricle. The central opening also allows for the placement of a blood flow control means. The blood flow control means can comprise a pumping balloon and a proximal blocking balloon, the two members pressurized and depressurized in opposition within the aorta of a patient to simulate systole and diastole of a healthy heart. The pumping balloon has a pressurized pumping position that is engaged while the proximal blocking balloon is in a depressurized deflated position.

Devices, systems and methods are disclosed for the formation of an arteriovenous fistula in the limb of the patient. Embodiments include an apparatus for the creation, modification and maintenance of a fistula, including the modification of an existing dialysis fistula; and a method of supplying oxygenated blood to the venous circulation of a patient. A kit of anastomotic implants is described which supports a broad base of patient anatomies and fistula locations. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respiratory failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.

A method of cufflessly and non-invasively measuring blood pressure in a wrist region of a patient in association with a communication device that relays the information being measured includes: detecting a magnitude difference between a plurality of pulse wave signals detected from a wrist of a user; detecting feature points from an electrocardiogram (ECG) and pulse wave signals detected from the user; extracting variables needed to calculate the highest blood pressure and the lowest blood pressure using the detected feature points; and calculating the highest blood pressure and the lowest blood pressure of the user by deducing a scatter diagram using the extracted variables.

The present invention relates to the field of using fruits dregs to perform deep-processing technique, specifically to a deep-processing process of kiwi berry dregs. The present invention provides a deep-processing process of kiwi berry dregs for overcoming the problem existing in the prior art such as increased enterprise cost, environment pollution and kiwi berry resource waste. The technical program of the invention is deep-processing process of kiwi berry dregs including in sequence the following steps: first, kiwi berry dregs pretreatment; second, primary fermentation; third, a secondary fermentation; fourth, post-processing. The invention has advantages as follows: the produces kiwi berry fruit vinegar has a certain health care functions: promote appetite strengthen spleen, relieve smell dehumidification, the elimination of fatigue, lower blood pressure, increase appetite, promote digestion, protect skin, the treatment of colds and respiratory diseases.

A method and device to prevent and cure body diseases caused by infection factors such as: bacteria, virus, fungi, parasites as well as preventing fat accumulation in body blood vessels, lowering blood pressure, lowering cholesterol level in the blood and destroying body organs cancer cells is done by inhaling vapors of fresh crushed or sliced garlic or vapors of synthetic allicin.

A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.

The present invention relates to pharmaceutical compositions for reducing essential hypertension and systemic inflammation. While many drugs have been found to treat hypertension, the currently available drugs often do not maintain reduced blood pressure at the preferred norm of 115 / 75 mm Hg or less throughout a 24 hour period. The current invention provides compositions comprising at least one hypertensive drug combined with the natural product Coenzyme Q10 (ubiquinone or CoQ10), which synergizes with the antihypertensive drugs to maintain low blood pressure throughout the day and night while generating other positive effects on the risks of cardiovascular disease, renal failure, and stroke. CoQ10 also counteracts some of the side effects of some hypertensive drugs such as tiredness, weakness, and / or liver toxicity. The invention further describes therapeutically effective methods for reducing systemic inflammation in hypertensive mammals comprising treatment with an antihypertensive composition that includes at least one angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and CoQ10 (ubiquinone). The invention metrics for reducing systemic inflammation comprise the reduction of serum levels of high sensitivity C-reactive protein (CRP), Interleukin 6 (IL-6), and / or tumor necrosis factor-alpha (TNF-alpha). These antihypertensive-CoQ10 combinations will synergistically reduce both hypertension and systemic inflammation.

The invention discloses an anti-hypertensive pig-bone-powder tea beverage and a preparation method thereof. The anti-hypertensive pig-bone-powder tea beverage comprises: 7-9 parts of green tea, 8-10 parts of pig bone, 1.2-1.4 parts of mythic fungus, 0.8-1 part of sunflower flower, 0.6-0.8 part of calcium fruit leaf, 1-1.2 parts of eucommia, 0.5-0.7 part of pecan, 0.8-1.0 part of fig, 0.8-1 part of phyllanthus emblica, 0.8-1.3 parts of citric acid, 0.8-1 part of vitamin C, 40-55 parts of glucose, and proper amount of a natural essence. The tea beverage of the invention caters to market demand and has a unique taste; besides proteins, fats and vitamins, the added pig bone also contains nutrient compositions required by human body, such as a large quantity of calcium phosphate, ossein, osseomucoid and the like; and mythic fungus has inhibition effect on nerve system, and effects of lowing blood pressure and reinforcing heart contraction force on circulatory system, expectorant effect on respiratory system, and additionally has effects of protecting liver, raising immunization function, antibiosis and the like.

The invention belongs to the technical field of high blood pressure regulating products, and in particular relates to a wearable blood pressure regulating device. The wearable blood pressure regulating device comprises a wearable blood pressure monitoring device and a microneedle type blood pressure dosing device, wherein the microneedle type blood pressure dosing device comprises a wearable wristband, a microneedle medicine device mounted on the wearable wristband, and a spring device mounted on the wearable wristband and used for starting the microneedle medicine device for realizing dosing for the human body, and when the blood pressure value monitored by the wearable blood pressure monitoring device exceeds the set range value, the spring device starts the microneedle medicine device for realizing dosing. The wearable blood pressure regulating device is simple in structure and convenient to use, and can carry out dosing immediately according to the abnormal condition of the blood pressure while monitoring the blood pressure, so that the blood pressure is timely and effectively regulated, thus the blood pressure is maintained to be at a stable numerical value, and finally, the body health of hypertension or hypotension patients is guaranteed.

The invention belongs to the technical fields of medicine and food homology formulas and new resource foods, and provides a medical formula food for treating coronary heart disease with specific or unspecific medical formula. According to the requirement of the General Rule for Food for Special Medical Purpose and the constitutive characters of a patient with coronary heart disease, based on the traditional Chinese medicine quintessence theory of reasonable compatibility of multiple traditional Chinese medicines characterized in homology of medicine and food, medical and edible traditional Chinese medicine extract essence extracted through semi-bionic extraction, multiple microencapsulated probiotics, and oligopeptide, prebiotics, amino acid, carbohydrate, grease with healthcare function, multivitamin and minerals extracted through biological enzymolysis are mixed to obtain the medical formula food. The medical formula food not only can meet the nutritional requirement of the patient as the single nutrition source, but also can resist aging, bacteria and inflammation, calm nerves, dilate vessels, reduce blood pressure and blood glucose and enhance immunity.

The present invention relates to methods of reducing blood pressure in a subject by administering a plasma kallikrein inhibitor.

The present invention belongs to the technical field of medicinal and edible food formulas and new resource foods and specifically provides non-whole nutrient formula food, special whole nutrient formula food or whole nutrient formula food for patients with coronary heart disease to eat. According to the requirements of General Principles of Special Medical Use Formula Foods, in combination with the constitutive characters of the patients with coronary heart disease, and based on the essence of traditional Chinese medicine theory, a variety of medicinal and edible traditional Chinese medicines are reasonably combined; a plurality of types of traditional Chinese medicine extract essences which are extracted by a prehydrolysis SBE technology, oligopeptides extracted by biological enzymolysis, prebiotics, amino acids, carbohydrates, fats with healthcare functions, a plurality of types of vitamins and mineral substances are mixed and then treated by other processes, thereby obtaining the formula food. The formula food can be used as a single nutrient source to meet the nutritional requirements of the patients with coronary heart disease, and also has effects of resisting aging, resisting bacteria and inflammation, calming mind, expanding blood vessels, reducing blood pressure, reducing blood sugar and improving immunity.

The present disclosure relates to new enantiomers of tetrahydroisoquinoline derivatives and pharmaceutically acceptable salts thereof, their formulations and pharmaceutical compositions. Enantiomers of tetrahydroisoquinoline derivatives are provided for heart rate stimulating and blood pressure lowering activity, inhibitory activity on platelet aggregation, and inhibition of inducible NO synthase activity. The enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts are useful in the treatment of congestive heart failure, hypertension, thrombosis, inflammation, sepsis, cardiac insufficiency, and disseminated intravascular coagulation.

The invention discloses an anti-cancer and blood pressure-lowering noodle, which is made of the following raw materials by weight part: 70-80 of wheat, 45-55 of rice, 30-40 of millet, 10-12 of cactus lyophilized powder, 10-12 of rape pollen, 20-30 of bovine bone marrow, 8-10 of osmanthus fragrans, 1-2 of Plantain Herb, 2-3 of Phlomis mongolica, 1-2 of radix isatidis, 4-5 of ginkgo leaves, 3-4 of red claw ginger, 20-24 of radix puerariae, 5-6 of grape seed oil, 1-2 of a noodle additive, and a proper amount of water. The noodle provided by the invention adopts wheat, rice, and millet as the main raw materials. The millet has the effects of benefiting spleen and stomach, nourishing kidney qi, promoting dieresis and the like. The bovine bone marrow can moisten lung, tonify kidney, and enrich marrow. The osmanthus fragrans has the effects of dissipating cold and breaking stagnation, reducing phlegm and relieving cough, improving beauty, and relieving throat, etc. The radix puerariae can enhance the regeneration capacity of liver cells, strengthen the liver detoxification function, promote metabolism, clear heat and help produce saliva, lower blood pressure and blood lipid, prevent and resist cancer, beautify skin and improve appearance, etc. The grape seed oil has the effects of resisting oxidation, lightening color spots, regulating internal secretion, delaying aging, and preventing cancer, etc.

The invention relates to a water-soluble algin oligose beverage which is characterized by consisting of water-soluble algin oligose, citric acid, sugar, fruit juice and water, wherein, the weight percent range of the water-soluble algin oligose is 0.01 percent to 20 percent, the weight percent range of the citric acid is 0.0001 percent to 5 percent, the weight percent range of the sugar is 0.001 percent to 20 percent, the weight percent range of the fruit juice is 0.001 percent to 50 percent and the rest is water. The beverage contains the active ingredient of sea plants, i.e., the algin oligose of a dietary fiber in seaweed, thus having the functions of preventing astriction and intestinal diseases, removing heavy metals and free radicals in human body, preventing angiocardiopathy, diabetes and mammary cancer, preventing and curing gall-stone, reducing blood pressure, improving immunocompetence of human body, and the like. The reasonable confection of varied components can effectively improve the nutrition, taste and flavor of the beverage.

Devices and methods are disclosed to address blood pressure control. More particularly, the present invention relates to correction of transient low blood pressure.